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Summary
Objective: Mesenchymal stem cells (MSCs) are a population of cells broadly discussed to support cartilage repair. The differentiation of MSCs
into articular chondrocytes is, however, still poorly understood on the molecular level. The aim of this study was to perform an almost genome-
wide screen for genes differentially expressed between cartilage and MSCs and to extract new markers useful to deﬁne chondrocyte differ-
entiation stages.
Methods: Gene expression proﬁles of MSCs (n¼ 8) and articular cartilage from OA patients (n¼ 7) were compared on a 30,000 cDNA-
fragment array and differentially expressed genes were extracted by subtraction. Expression of selected genes was assessed during in vitro
chondrogenic differentiation of MSCs and during dedifferentiation of expanded chondrocytes using quantitative and semi-quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR). Protein secretion was measured by enzyme-linked immunosorbent assay.
Results: Eighty-seven genes were differentially expressed between MSCs and cartilage with a more than three-fold difference. Sixty-seven of
them were higher expressed in cartilage and among them 15 genes were previously not detected in cartilage. Differential expression was
conﬁrmed for 69% of 26 reanalysed genes by RT-PCR. The proﬁles of three unknown transcripts and six protease-related molecules were
characterised during differentiation. SERPINA1 and SERPINA3 mRNA expression correlated with chondrogenic differentiation of MSCs
and dedifferentiation of chondrocytes, and SERPINA1 protein levels in culture supernatants could be correlated alike.
Conclusions: cDNA-array analysis identiﬁed SERPINA1 and A3 as new differentiation-relevant genes for cartilage. Since SERPINA1 secre-
tion correlated with both chondrogenesis of MSCs and dedifferentiation during chondrocyte expansion, it represents an attractive marker for
reﬁnement of chondrocyte differentiation.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Mesenchymal stem cells (MSCs), which can be found in dif-
ferent adult organs, are broadly discussed as a cell popula-
tion able to support cartilage regeneration. The potential of
MSCs from bone marrow or adipose tissue to differentiate
towards the chondrogenic lineage has been established1,2,3
and various approaches are tested in vitro for the use of
MSCs to generate tissue engineered cartilage4. Differentia-
tion of MSCs into articular chondrocytes, spontaneous re-
generation of injured cartilage and repair after surgical
treatments like microfracture or autologous cell therapy
(ACT) are, however, still poorly understood on the molecu-
lar level. To support a better understanding of cartilage dif-
ferentiation and regeneration, there is a need for multiple
marker genes allowing a precise characterisation of distinct
cell differentiation stages.*Address correspondence and reprint requests to: Dr Wiltrud
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48The cartilage transcriptome has been estimated to repre-
sent between 13,200 and 15,800 genes5. A few studies
have compiled repertoires of gene expression in cartilage
by sequencing foetal cartilage cDNA libraries6,7 or adult
osteoarthritic (OA) and healthy cartilage cDNA libraries8.
This provided an overview on a high amount of genes
expressed in the concerned tissue but only weak indica-
tions on the expression levels of genes. More quantitative
microarray-based approaches allow comparative gene
expression analyses. These approaches have been used
for comparison of healthy with OA cartilage9, or for the com-
parison of different types of cartilage-like hyaline cartilage
and ﬁbrocartilage10. Several studies compared cartilage to
dedifferentiated chondrocytes in order to identify chondro-
genesis associated genes11,12. On the other hand, expres-
sion proﬁles of MSCs have been well characterised and
compared between different sources like human bone
marrow-derived stem cells (BMSCs)13 or adipose tissue-
derived stromal cells (ATSCs)14. Comparative gene expres-
sion analysis has also been undertaken for BMSCs and
ﬁbroblasts15, while differentiation-relevant evaluation of
gene expression proﬁles of MSCs in comparison to hyaline
cartilage is lacking.
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allow ﬁnding new markers relevant for differentiation of pro-
genitor cells into functional chondrocytes in permanent artic-
ular cartilage. The aim of this study was to identify such new
marker genes for characterisation of chondrocyte differentia-
tion. We performed an almost genome-wide screen (30,000-
gene fragments) for transcripts expressed in seven cartilage
and eight MSC samples and extracted possible marker
genes by bioinformatic subtraction. Potential candidate
genes were then assessed for their relevance as differentia-
tion markers during chondrogenesis of MSCs and dediffer-
entiation of chondrocytes expanded in monolayer culture.Material and methodsTISSUE SAMPLESHealthy cartilage samples were obtained from the knees
from ﬁve patients undergoing amputation. OA cartilage
samples were obtained from 10 patients undergoing total
knee arthroplasty (age from 54 to 82). Cartilage chips
were carefully removed from the tibial plateau and condyles
and washed with phosphate buffered saline (PBS) to avoid
contamination by other cells. Bone marrow samples for iso-
lation of mesenchymal stem cells (BMSCs) were obtained
from ﬁve patients (age from 26 to 53) undergoing total hip
replacement or iliac bone graft harvest. ATSCs (n¼ 5)
were isolated from lipoaspirates generated during elective
liposuction procedures or from adipose tissue samples ob-
tained from patients undergoing total hip arthroplasty (age
from 21 to 53). The studies were approved by the local
ethics committee and informed consent was obtained
from all individuals included in the study.CELL ISOLATION AND CULTIVATIONMSCs were isolated from fresh bone marrow samples as
described previously3. Brieﬂy, cells were fractionated on
a Ficoll-Paque Plus density gradient (Amersham Pharma-
cia, Uppsala, Sweden), and the low-density MSC-enriched
fraction was washed and seeded in culture ﬂasks in MSC
culture medium16 containing 2% foetal calf serum (FCS),
with 10 ng/ml recombinant human epidermal growth factor
(Strathmann Biotech, Hamburg, Germany) and 10 ng/ml
recombinant human platelet-derived growth factor BB
(SigmaeAldrich, Deisenhofen, Germany). After 24e48 h,
cultures were washed with PBS to remove non-adherent
material. During expansion, medium was replaced twice
a week.
ATSCs were isolated according to the method described
by Hauner et al.17. Brieﬂy, minced tissue or lipoaspirates
were digested with KrebseRinger solution buffered with
25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), 20 mg/ml bovine serum albumin (BSA), and
1.5 mg/ml collagenase (CLS type I; Worthington, Freehold,
NJ) and ﬁltered with a 250-mm nylon mesh. Erythrocytes
were removed using erythrocyte lysis buffer (0.154 M
NH4Cl, 10 mM KHCO3, 0.1 mM ethylenediamine tetraacetic
acid (EDTA). The remaining cells were seeded in culture
ﬂasks and maintained under conditions identical to those
for BMSCs.
Human chondrocytes were isolated from cartilage by di-
gestion with collagenase B (1.5 mg/ml) (Roche Diagnostics,
Mannheim, Germany) and hyaluronidase (0.1 mg/ml)
(Serva, Heidelberg, Germany), as described previously12.
Cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% FCS, 100 units/ml ofpenicillin, and 100 mg/ml of streptomycin, and were main-
tained at 37C in a humidiﬁed atmosphere and 6%CO2. Dur-
ing expansion, medium was replaced twice a week. Cells
were seeded in order to achieve conﬂuence after six popula-
tion doublings (pd6) and counted for determination of popu-
lation doublings achieved. Chondrocytes were harvested
directly after collagenase/hyaluronidase digestion (pd0) as
well as after two (pd2) or six (pd6) population doublings.INDUCTION OF OSTEOGENIC AND ADIPOGENIC
DIFFERENTIATION OF BMSCs AND ATSCsMSCs were seeded in six-well plates at 1e3 104 cells/
cm2. For osteogenic induction, medium was switched to
MSCs’ growth medium (Poietics; BioWhittaker, Taufkirchen,
Germany) supplemented with 0.1 mM dexamethasone,
0.05 mM ascorbic acid-2-phosphate, and 10 mM b-glycero-
phosphate for 2 weeks. Adipogenic medium composed of
DMEM high glucose (DMEM-HG) containing 10% FCS,
0.01 mg/ml insulin, 1 mM dexamethasone, 0.2 mM indo-
methacin, 0.5 mM 3-isobutyl-1-methyl xanthine, 100 units/
ml penicillin, and 100 mg/ml streptomycin was applied for
2 weeks. After ﬁxation of washed cells in 4% paraformalde-
hyde, they were stained with von Kossa or Oil red O as
described previously3.INDUCTION OF CHONDROGENIC DIFFERENTIATION OF
BMSCs AND ATSCsFor induction of chondrogenesis at high cell density in
three-dimensional culture, spheroids of 4e5 105 cells
were formed by centrifugation at 300 g in 1.5 ml microcen-
trifuge tubes (Eppendorf, Hamburg, Germany). After incu-
bation at 37C, 6% CO2 for 4 days, spheroids were
transferred to 96-well cell culture plates. Cells were kept
in induction medium for 14, 28 or 42 days. Chondrogenic
medium consisted of DMEM-HG (DMEM containing
4.5 mg/l glucose) supplemented with 5 mg/ml insulin, 5 mg/
ml tranferrin, 5 mg/ml selenous acid, 0.1 mM dexametha-
sone, 0.17 mM ascorbic acid-2-phosphate, 1 mM sodium
pyruvate, 0.35 mM proline, 1.25 mg/ml BSA and 10 ng/ml
transforming growth factor b3 (TGF b3; SigmaeAldrich).
Medium for ATSCs was additionally supplemented with
10 ng/ml BMP6 (R&D systems).RNA EXTRACTIONTotal RNA was isolated from cultured cells using a stan-
dard guanidinium thiocyanate/phenol extraction protocol
(peqGOLD RNAPure; Peqlab, Erlangen, Germany). Poly-
adenylated mRNA was then isolated with oligo-d(T)-
coupled magnetic beads (Dynabeads; Invitrogen) according
to the manufacturer’s instructions. For the isolation of RNA
from tissue samples of cartilage, shock-frozen tissue was
pulverised mechanically and consecutively dissolved in
lysis/binding buffer for direct poly(A)þ-mRNA isolation using
oligo-d(T)-coupled beads (Dynabeads; Invitrogen).cDNA-ARRAY ANALYSISThe human Unigene Set e RZPD1 array (RZPD, Berlin,
Germany) with 31,488 clones was used for hybridisation.
mRNA isolated from 10 OA cartilage samples and from
10 MSC (n¼ 5 ATSCs, n¼ 5 BMSCs) samples was re-
verse-transcribed to 33P-labeled cDNA probes according
to the manufacturer’s protocol (SuperScript II, Invitrogen).
50 S. Boeuf et al.: Gene expression of cartilage and MSCsThe labelled cDNAs were denatured and hybridised to
cDNA arrays in 5Denhardt’s solution, 6 Saline-sodium
citrate (SSC)/0.25% sodium dodecyl sulfate (SDS) and
50 mg/ml salmon sperm DNA overnight at 65C. Arrays
were washed 3 30 min in 0.04 M sodium phosphate
buffer, pH 7.2/1% SDS at 65C. Arrays were exposed to
a phosphor imaging plate for up to 72 h. Images were cap-
tured on a Bio-Imaging Analyser BAS-1800 II using BAS
Reader 2.26 beta software (Fuji/Raytest, Straubenhardt,
Germany). The hybridisation with one of the cartilage sam-
ples was of poor quality and rejected for that reason.
Spots were quantiﬁed with the Arrayvision software (Im-
aging Research Inc., St. Catharines, Ontario, Canada).
Background-corrected intensity values were normalised
and transformed to generalised log ratios through the vari-
ance stabilising method18. The normalised data are pre-
sented in Supplementary Table 2. The comparison
between cartilage and stem cell probes was performed us-
ing the Signiﬁcance Analysis of Microarrays software pack-
age (SAM19). Background-corrected signal intensities
normalised to the mean signal of each array were used
for the calculation of fold changes. The normalised signal in-
tensities were evaluated for homogeneity on scatter plots by
pair-wise comparison of all hybridisations from one group.
Two cartilage and two stem cell samples showed a bimodal
conﬁguration of the scatter plot when compared to all the
other samples, indicating divergent expression proﬁles.
These samples were excluded from further analysis and
evaluation was based on seven cartilage and eight stem
cell samples.SEQUENCE ANALYSISThe clones identiﬁed on the cDNA arrays were pur-
chased from RZPD. Plasmid DNA was prepared with theTable
List of primers used for reverse transcriptase-pol
Gene Forward primer (50 to 30)
ACTB GTGGCATCCACGAAACTACC
C5orf4 TAACTTCATCTCTCGCTACC
CALU TGTGGTGGGAAGAGTTAGG
CCDC95 GACGGCGAAGTGGACTAC
CLU TTCTACTTCTGGATGAATGGT
COL2A1 TGGCCTGAGACAGCATGAC
FLJ21986 GGCTATGAAGTAGTTGACAC
GAPDH CCACCCATGGCAAATTCCATGGC
HTRA1 CAAGGATGTGGATGAGAAAG
IFI44L CTGTGTGGCTTATGTCTTAG
KIAA0746 CTAGCAGTTATAAGGCACCT
LGALS1 TGGACTCAATCATGGCTTGT
LOC112868 CTTGTTGCGATTCTTCTGTG
LOC25845 GGAAGCGTCAGCCACACA
LOC285733 TCCTCCTCATCGCCTACTT
M96 ATGGGAAAGCATATTGGGAC
MMP15 CTCTCAGCCCTCACACAC
MMP3 TTTTGATGGACCTGGAAATG
PCSK1N GTGTGAAACGCCTAGAGAC
PDE4DIP AGAACGAGTCACACAGCAG
PLA2G2A TGGTGAATTTCCACAGAATGA
SERPINA1 GACACCGAGGAAGAGGAC
SERPINA3 TGAGGCAGAAATTCACCAGA
SERPINF1 TAGACCGAGAACTGAAGACC
SETD5 AGATATGAACATGGCTTAATGA
SPRN ACAGGAGAGACATGGAGTG
SURF4 GTCTTGCTGGTTCTGATGTT
TAGLN GTCCTTCCTATGGCATGAG
TIEG2 GTTGCCGGAAGACCTACTTQiagen plasmid miniprep kit (Qiagen), and given for insert
sequencing to MWG Biotech (Ebersberg, Germany). Basic
local alignment search tool (BLAST) algorithms were used
to screen for DNA and protein sequence similarities in pub-
lic databases at the National Center for Biotechnology Infor-
mation (NCBI).DESIGN OF A CUSTOMISED cDNA ARRAY COMPRISING
230 GENE FRAGMENTSThe 87 genes identiﬁed by cDNA-array analysis as well
as further 139 genes selected by literature search and
four housekeeping genes were chosen for the design of
a customised cDNA array (Supplementary Table 1). cDNA
fragments were ampliﬁed by polymerase chain reaction
(PCR) from corresponding clones and were spotted on
nylon membranes using a Biogrid spotter (Genomic
solutions). The expression levels of the four housekeeping
genes (b-actin (ACTB), glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH), RPL13A and RPS9) were used for
the normalisation of signals.RT-PCRReverse transcription was performed with poly(Aþ)-
mRNA by using reverse transcriptase Superscript II (Invitro-
gen) and oligo-d(T) primers. The ﬁrst strand cDNA was
subjected to PCR. Oligonucleotide sequences used for
PCR and Light-Cycler analysis are listed in Table I. Oligo-
nucleotides were obtained from MWG Biotech (Ebersberg,
Germany) and Thermo Electron (Ulm, Germany). PCR
was performed with 1 ml template in a total volume of
50 ml containing 200 nM of each primer, 1.5 mM MgCl2,
200 mM dNTPs, 1 PCR buffer and 1.5 U Taq-polymerase
(Invitrogen). PCR conditions consisted of 4 min initiation atI
ymerase chain reaction (RT-PCR) analysis
Reverse primer (50 to 30)
GTACTTGCGCTCAGGAGGAG
ATAGAGAGAGATCACGCCAAT
CAACCAAACTCATAACTAATACT
TCATCCACGTTCTCGTACTG
GGGCTGTGGAAGTGGATG
AGTGTTGGGAGCCAGATTGT
GGCTCCTAGACCATTGTCC
A TCTAGACGGCAGGTCAGGTCCACC
GTGTTAATTCCAATCACTTCAC
AGCATAATTTCCAACCATCAAA
CTTCCTCTTCCTCTCTAACA
ACATTTGATCTTGAAGTCACC
GCAATCGTCATGTTTAGAGAA
CGCTCCTGCTCTGTTCTC
CTGCTGTTATACTGAGTCTCT
AAGCCCACCCAATACTACAA
GTGGAAGGCTCTTCCTAAG
CTCACGGTTGGAGGGAAAC
TTGCTTCAGATCATGTTTATTG
AGTGTTCCGCTTGTAGATGT
ACACTCACACAGTTGACTTCT
GAGGAGCGAGAGGCAGTT
GTCGTTGATGAGCTTCTTAG
CTTCGTGTCCTGTGGAATCT
ATCCACCTACTGCTGATATTC
GGGTGCTGGTCTTGACTTT
GACTGAGCCATCGATTCTC
TCTGGAACATGTCAGTCTTG
AGCCTGGGATCTTCTTGGT
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annealing at 58C and 45 s extension at 72C; and a ﬁnal
5 min extension at 72C. Depending on signal intensities,
25 to 35 cycles were performed. For templates to be com-
pared, GAPDH was used as reference to adjust the tem-
plate cDNA concentrations.REAL-TIME RT-PCRTo quantify the mRNA levels with the Light-Cycler (Roche
Diagnostics, Mannheim, Germany) aliquots of ﬁrst-stranded
cDNAs were ampliﬁed using gene-speciﬁc primer sets
(Table I) and real-time ﬂuorimetric intensity of CYBR green
I was monitored. The Cycling parameters were optimized
according to the Light-Cycler protocol from Roche (Light-
Cycler Operator’s Manual, Version 3.5, October 2000).
The concentration of the housekeeping gene b-actin
(ACTB) was used as the control reference gene. It was de-
tected at the same level in all cell types. The ACTB concen-
tration was determined once for each cDNA sample and
used to normalize all other genes tested for the same
cDNA sample. Melting curves and agarose gel electropho-
resis of the PCR products were used as quality controls.ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)For ELISA of supernatants from expanded chondrocytes,
5 105 cells were seeded in six-well plates and supple-
mented with 4 ml DMEM medium. For ELISA of superna-
tants from differentiating BMSCs, spheroids (5 105 cells)
were supplemented with 200 ml chondrogenic medium.
For both types of cell culture, supernatants were collected
after 4 days. SERPINA1 (or a1-antitrypsin) protein was de-
tected with the a1-antitrypsin ELISA kit (Immundiagnostik,
Bensheim, Germany) according to the manufacturer’s in-
structions. Supernatants were diluted in DMEM medium in
order to achieve concentrations in the range of the corre-
sponding standard curve.WESTERN BLOT ANALYSIS5 106 freshly isolated chondrocytes were expanded for
3 days in 20 ml of DMEM with 10% FCS. Medium was then
switched to serum-free and the cells conditioned for 3 days.
Concentrated medium (Vivaspin 20 centrifugal ﬁlter de-
vices; 10,000 MWCO; Vivascience, Stonehouse, UK) was
subjected to Western blotting. Proteins were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
and transferred to nitrocellulose (Hybond C super; Amer-
sham Pharmacia Biotech, Freiburg, Germany). The ﬁlter
was blocked with 2% BSA in Tris-buffered saline (TBS)/
Tween (25 mM Tris/HCl pH 7.4; 145 mM NaCl, 2.7 mM
KCl, 0.1% Tween 20) overnight and incubated for 2 h with
rabbit anti-SERPINA1 antibody (1:1000; Assaypro, St
Charles, USA). After washing, ﬁlters were incubated with an
alkaline phosphatase-conjugated secondary goat anti rabbit
antibody (1 h, 1:10,000; Dianova, Hamburg, Germany) and
stained with nitro-blue-tetrazolium/5 bromo-4-chloro-3-
indolylphosphate. Human plasma a1-antitrypsin (Sigmae
Aldrich, Germany) was used as positive control.STATISTICAL ANALYSISMean and standard deviation were calculated for all
values. The ManneWhitney U test was chosen to evaluate
differences in gene expression levels between cartilage andMSCs assessed by real-time RT-PCR. This non-parametric
two-tailed test is not based on assumptions about the distri-
bution of expression values or the equality of variance. For
the real-time RT-PCR data of differentiating BMSCs,
Monte-Carlo one-tailed P values were calculated based on
the Wilcoxon rank sum test. For the analysis of protein se-
cretion levels for SERPINA1 in dedifferentiating chondro-
cytes, analysis of variance (ANOVA) was chosen after
veriﬁcation of normal distribution and equality of variance.
For all tests a P value< 0.05 was considered signiﬁcant.
Data analysis was performed with SPSS for Windows
(SPSS, Chicago, USA).ResultsDEFINITION OF THE MSC CULTURES FROM BONE MARROW
AND ADIPOSE TISSUEMSCs from two different origins, BMSCs and ATSCs,
were chosen for this analysis in order to avoid the identiﬁca-
tion of genes speciﬁcally related to osteoblast or adipoblast
progenitor cells. Expanded BMSCs and ATSCs were
checked for the expression of MSC surface markers like
CD29, CD44 or CD105. All cultures were negative for
CD34. The adipogenic, osteogenic and chondrogenic poten-
tial of analysed MSCs was conﬁrmed by histology (Fig. 1).IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES
BY cDNA-ARRAY ANALYSISThe expression levels of 31,188 transcripts in seven
cartilage tissue samples and eight undifferentiated MSC
samples were assessed. Four hundred six spots with signif-
icantly differential signals between cartilage and MSC
samples were identiﬁed by the SAM software when the
false discovery rate was set at 3.3%. Out of them, 105
showed a more than three-fold difference in expression
levels between cartilage and MSC and were selected for
further analysis. Four of the corresponding clones were
not available from the provider; the others were purchased
and sequenced. Since 14 genes were found to be repre-
sented twice in this list, 87 sequences with signiﬁcantly
different expression levels were ﬁnally identiﬁed by this
analysis.GENES DIFFERENTIALLY EXPRESSED BETWEEN
CARTILAGE AND MSCsSixty-seven genes showed higher expression levels in
cartilage than in MSCs. They are listed in Table II, sorted
according to the cellular localisation of the gene products.
The genes with the highest mean expression levels in
cartilage were clusterin, TGFb-inducible-early-growth-re-
sponse 2 (TIEG2), serine (or cysteine) proteinase inhibitor
clade A member 1 (SERPINA1) and the ADP-ribolysation-
like factor 6 interacting protein 2 (ARL6IP2). A high amount
of secreted proteins, membrane-bound proteins or proteins
of the extracellular matrix was found (45%). Fourteen genes
corresponded to proteins with unknown localisation (21%)
and 23 genes represented intracellular and nuclear prod-
ucts (34%). According to the iCartiGD database20, 15 of
these genes were so far not described to be expressed in
cartilage.
Twenty genes showed higher expression levels in MSCs
than in cartilage (Table III). Of them only four genes corre-
sponded to secreted products (20%). Three genes associ-
ated to the cytoskeleton, and no genes associated to
Fig. 1. Multilineage differentiation potential of BMSCs (AeC) and ATSCs (DeF). Oil red O staining of adipogenic cultures shows cell bodies
ﬁlled with numerous lipid vesicles (A and D). Osteogenic cultures deposited mineralised extracellular matrix, as indicated by von Kossa stain-
ing (B and E). After chondrogenic differentiation in spheroid cultures a cartilage-like matrix was synthesised, as indicated by immunostaining of
parafﬁn sections for type II collagen (C and F).
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MSCs and cartilage were evident for transgelin and galectin
1 which, thus, deserve further attention as possible markers
for undifferentiated cells. Further, two unknown transcripts
with higher expression levels in MSCs were identiﬁed.
A customised cDNA array comprising all differentially ex-
pressed genes together with known cartilage or stem cell
relevant gene fragments was produced for further analysis
(total 230 genes listed in Supplementary Table 1). Gene ex-
pression proﬁles of the cartilage and MSC samples used for
the genome-wide screening were assessed on this custom-
ised cDNA array for quality control.CONFIRMATION OF GENE EXPRESSION RESULTS BY RT-PCRThe cDNA array results were further revaluated by quan-
titative RT-PCR as a second method using four indepen-
dent cartilage and BMSC samples, respectively. Focus
was on genes with highly differential expression levels
and transcripts of unknown genes. Altogether 26 genes
were revaluated and differential expression was conﬁrmed
for 18 (69%) of them (details in Tables II and III).
Several proteinases and proteinase inhibitors were con-
ﬁrmed to be higher expressed in cartilage by RT-PCR[Fig. 2(A)]: SERPINA1, SERPINA3, matrix metalloprotei-
nase 3 (MMP3), the proprotein convertase inhibitor
PCSK1N and the protease HTRA1. Serine (or cysteine)
proteinase inhibitors (SERPIN) are a superfamily of proteins
functioning mainly as inhibitors of proteinases of the chymo-
trypsin family21. While SERPINA1 and SERPINA3 showed
higher expression in cartilage vs MSC (356-fold and
37-fold, respectively, according to real-time RT-PCR;
P< 0.05; data not shown), the slightly higher expression
levels of SERPINF1 in MSC (2.3-fold) did not reach signif-
icance. MMP3 mRNA levels were 467-fold higher in carti-
lage than in MSC (P< 0.05). PCSK1N could not be
ampliﬁed by real-time RT-PCR, whereas for HTRA1
seven-fold higher expression levels were found in cartilage
(P< 0.05).
Out of 11 tested transcripts of unknown genes or so far
poorly described genes (as SPRN, PDE4DIP), seven
were conﬁrmed to be differentially expressed between
MSCs and cartilage according to RT-PCR [Fig. 2(B)].
Real-time PCR demonstrated that the hypothetical protein
KIAA0746 was higher expressed in MSC than in cartilage
(20-fold), while the genes LOC25845, SETD5, C5orf4,
PDE4DIP and SPRN all showed a four- to ﬁve-fold higher
expression in cartilage (P< 0.05; data not shown). All
Table II
Classification of genes expressed in cartilage at significantly higher levels (>three-fold) compared to MSCs
Localisation Mean
cartilage
Mean
MSCs
Fold Symbol Gene name Accession
Secreted 193.3 2.8 68.0 CLU Clusterin* BC019588
24.2 0.5 46.6 PLA2G2A Phospholipase A2, group IIA* NM_000300
35.4 0.8 45.3 SERPINA1 Serine (or cysteine) proteinase inhibitor, clade A, member 1* BC015642
3.2 0.5 6.7 SERPINA3 Serine (or cysteine) proteinase inhibitor,
clade A, member 3*
NM_001085
6.1 1.1 5.6 CTGF Connective tissue growth factor NM_001901
3.3 0.7 4.6 AEBP1 AE (adipocyte enhancer) binding protein 1 (ACLP) NM_001129
1.7 0.4 4.3 ANGPTL2 Angiopoietin-like 2 NM_012098
2.2 0.6 3.7 PCSK1N Proprotein convertase subtilisin/kexin type 1 inhibitor* NM_013271
1.7 0.5 3.6 MMP3 MMP3* X05232
40.6 11.7 3.5 HTRA1 HtrA serine peptidase 1 (PRSS11)* NM_002775
2.7 0.8 3.3 CFH Complement factor H NM_000186
1.9 0.6 3.2 CFB Complement factor B NM_001710
Extracellular matrix 27.6 0.8 33.1 PRELP Proline arginine-rich end leucine-rich repeat protein U29089
13.1 0.6 20.8 FMOD Fibromodulin U05291
13.7 0.8 16.5 AGC1 Aggrecan 1 NM_013227
34.0 2.4 14.2 DCN Decorin BC005322
8.0 0.6 13.8 COL2A1 Collagen, type II, alpha 1 X16158
3.9 0.6 6.8 COL11A1 Collagen, type XI, alpha 1 J04177
4.4 0.7 6.6 LUM Lumican U18728
3.7 0.6 6.4 TNXB Tenascin XB NM_019105
2.8 0.6 5.0 CHI3L2 Chitinase 3-like 2 (YKL-39) U58514
2.2 0.5 4.6 HAPLN1 Hyaluronan and proteoglycan link protein 1
(cartilage linking protein 1)
U43328
3.5 0.8 4.2 SCRG1 Scrapie responsive protein 1 NM_007281
Cell membrane 6.3 0.5 13.8 MMP15 MMP 15 (membrane-inserted)y NM_002428
3.5 0.5 6.6 CD74 CD74 antigen BC018726
2.4 0.4 5.4 GYPA Glycophorin A NM_002099
3.1 0.7 4.7 CLSTN1 Calsyntenin 1 BC033902
3.2 0.7 4.4 ITGA10 Integrin, alpha 10 NM_003637
2.7 0.6 4.3 KEL Kell blood group NM_000420
1.6 0.5 3.4 FGFR3 Fibroblast growth factor receptor 3 NM_022965
Intracellular 17.2 0.8 21.9 SURF4 Surfeit 4y NM_033161
23.3 1.1 20.5 PDE4DIP Phosphodiesterase 4D interacting protein (myomegalin)* AB042558
31.3 1.9 16.8 ARL6IP2 ADP-ribosylation-like factor 6 interacting protein 2 BC053508
10.3 0.7 15.6 H19 H19 gene BC053637
10.9 0.8 12.8 NEDD4 Neural precursor cell expressed, developmentally
down-regulated 4
NM_006154
11.8 1.2 9.6 HIBADH 3-hydroxyisobutyrate dehydrogenase NM_152740
4.3 0.6 7.6 WWP2 Nedd-4-like ubiquitin-protein ligase NM_199424
8.0 1.3 6.3 RAB24 RAB24, member RAS oncogene family BC021263
2.5 0.5 5.4 S100B S100 calcium binding protein, beta NM_006272
5.5 1.3 4.3 SLK STE20-like kinase (yeast) U28250
1.9 0.5 4.3 FXYD6 FXYD domain containing ion transport regulator 6 NM_022003
2.1 0.5 4.0 CDO1 Cysteine dioxygenase, type I BC024241
1.7 0.5 3.5 MAP3K7IP1 Mitogen-activated protein kinase kinase kinase 7
interacting protein 1
NM_006116
2.1 0.7 3.1 TSC22 Transforming growth factor beta-stimulated protein TSC22 BC016867
Cytoskeleton 3.6 1.2 3.1 ARHGAP5 Rho GTPase activating protein 5 NM_001173
Nuclear 58.4 1.2 48.9 KLF11 Kruppel-like factor 11* NM_003597
20.6 0.7 30.3 M96 M96 protein* AF073293
6.8 0.7 9.2 CRIP1 Cysteine-rich protein 1 NM_001311
8.4 1.6 5.1 GLE1L GLE1 RNA export mediator-like (yeast) BC030012
2.1 0.5 4.4 MGA MAX gene associated AB011090
4.3 1.1 3.8 EGR1 Early growth response 1 NM_001964
2.1 0.6 3.5 MYB v-myb myeloblastosis viral oncogene homolog AJ616235
1.9 0.6 3.4 CRIP2 Cysteine-rich protein 2 NM_001312
Not deﬁned 21.6 1.0 21.4 SPRN Shadow of prion protein* BC040198
33.2 2.9 11.3 SETD5 SET domain containing 5* BC020956
9.7 1.0 9.5 ANKMY2 Ankyrin repeat and MYND domain containing 2 BC035353
4.9 0.9 5.7 DCDC2 Doublecortin domain containing 2 (KIAA1154 protein) AB032980
2.1 0.5 4.7 SULF2 Sulfatase 2 NM_018837
1.9 0.4 4.4 SAP30L SAP30-like BC009829
2.7 0.8 3.3 TMEM112 Transmembrane protein 112 BC036550
(continued on next page)
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Table II (continued )
Localisation Mean
cartilage
Mean
MSCs
Fold Symbol Gene name Accession
Unknown genes 10.9 0.6 19.6 C5orf4 Chromosome 5 open reading frame 4* BC004506
12.6 0.7 18.0 LOC25845 Hypothetical protein LOC25845* XM_376366
10.9 0.8 12.8 LOC285733 Hypothetical protein LOC285733y XM_379432
3.8 0.7 5.8 LOC112868 Hypothetical protein LOC112868* AL390134
2.9 0.7 4.0 FLJ11151 Hypothetical protein FLJ11151 BC006289
1.4 0.4 3.5 C16orf69 Chromosome 16 open reading frame 69 NM_153261
2.4 0.7 3.3 LOC91316 Similar to bK246H3.1 AK056875
*Differential expression was conﬁrmed by quantitative or semi-quantitative RT-PCR (P< 0.05). yDifferential expression could not be
conﬁrmed in all donors (n¼ 4).
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dates for further analysis as differentiation markers.EXPRESSION DURING IN VITRO CHONDROGENESIS OF MSCThe relevance of the selected genes as markers for chon-
drogenesis was evaluated during chondrogenic induction of
BMSC spheroids in vitro. Expression proﬁles were as-
sessed by real-time RT-PCR analysis in two to ﬁve donors
at days 0, 14, 28 and 42 after induction (Fig. 3). Consistent
with successful chondrogenesis, the expression levels of
COL2A1 were strongly induced over time. SERPINA1 was
up-regulated during induction, reaching signiﬁcantly higher
expression levels compared to the control after 4 and 6
weeks. Mean expression levels of SERPINA3 increased
alike (Fig. 3), yet at much lower levels of expression than
SERPINA1. The expression proﬁle of MMP3 reached high-
est mean expression levels after 14 days. Due to higher do-
nor variability, no signiﬁcance was reached for SERPINA3
and MMP3. HTRA1 expression was up-regulated in one do-
nor while for the second donor expression was relatively
stable during differentiation. For unknown genes likeTable I
Classification of genes expressed in MSCs at significant
Localisation Mean
cartilage
Mean
MSCs
Fold Symbol
Secreted 4.2 58.8 14.0 LGALS1 Lectin, ga
1.2 10.2 8.5 DF D compo
1.0 8.3 8.3 SERPINF1 Serine (o
0.9 4.0 4.4 ADM Adrenom
Intracellular 1.7 22.7 13.4 CALU Calumeni
4.4 17.1 3.9 MTRNR2 Mitochon
6.4 23.0 3.6 RPSA Ribosoma
Cytoskeleton 1.7 56.3 33.1 TAGLN Transgeli
1.4 13.4 9.6 TMSB10 Thymosin
2.3 20.0 8.7 TPM2 Tropomyo
Nuclear 1.8 10.6 5.9 POLR2L Polymera
0.6 3.5 5.8 COPS8 COP9 co
subunit 8
3.5 19.9 5.7 NIPBL Nipped-B
Not deﬁned 1.9 16.1 8.5 CCDC95 Coiled-co
6.5 41.9 6.4 API5 Apoptosis
1.2 6.3 5.3 IFI44L Interferon
4.2 18.6 4.4 S100A11 S100 Cal
6.4 23.0 3.6 WDR45L WDR45-l
Unknown genes 0.9 27.1 30.1 FLJ21986 Hypotheti
1.4 6.9 4.9 KIAA0746 KIAA0746
*Differential expression was conﬁrmed by quantitative or semi-quant
conﬁrmed in all donors (n¼ 4).C5orf4 (Fig. 3), LOC25845 and SETD5 (data not shown),
only low changes in gene expression were found during
chondrogenesis.EXPRESSION DURING DEDIFFERENTIATION OF
CHONDROCYTES IN MONOLAYER CULTUREGood differentiation markers would be expected to be
down-regulated during dedifferentiation of chondrocytes in
monolayer culture. Therefore, we analysed the expression
levels of the selected genes also in cartilage tissue, freshly
isolated chondrocytes and cells expanded for pd2 and pd6.
SERPINA1 and SERPINA3 were expressed in healthy car-
tilage as well as in OA cartilage. SERPINA1 was 2.06-fold
signiﬁcantly higher expressed in healthy cartilage than in
OA cartilage, whereas for SERPINA3 no differences were
found [Fig. 4(A)]. Both genes were expressed in freshly iso-
lated chondrocytes as well and their mRNA levels dimin-
ished during dedifferentiation in monolayer culture, parallel
to the decreasing expression levels of collagen type II
[Fig. 4(B)]. MMP3 mRNA was expressed at a low level in
cartilage but strongly up-regulated in freshly isolatedII
ly higher levels (>three-fold) compared to cartilage
Gene name Accession
lactoside-binding, soluble 1 (galectin 1)* BC020675
nent of complement, adipsin NM_001928
r cysteine) proteinase inhibitor, clade F, member 1* BC000522
edullin NM_001124
ny NM_001219
drion AF382013
l protein SA, 67 kDa (laminin receptor 1) BC008867
n* BC024296
, beta 10 NM_021103
sin 2 (beta) BC011776
se (RNA) II (DNA directed) polypeptide L NM_021128
nstitutive photomorphogenic homolog
(Arabidopsis)
NM_006710
homolog (IDN3 protein) NM_133433
il domain containing 95y BC047712
inhibitor 5 (FGF2-interacting factor, XAGL protein) BC017709
-induced protein 44, C1orf29y NM_006820
cium binding protein A11 (Calgizzarin) NM_005620
ike BC000974
cal protein FLJ21986y NM_024913
protein* BC009945
itative RT-PCR (P< 0.05). yDifferential expression could not be
Fig. 2. RT-PCR analysis of the expression of proteases and protease inhibitors (A) and of unknown transcripts and poorly described genes (B)
in cartilage and BMSCs. PCR was conducted with cDNA samples from cartilage and expanded BMSCs from two donors each. The concen-
tration of templates used in the reactions was adjusted according to GAPDH signals in order to achieve comparable signals. PCR products
were visualised by agarose gel electrophoresis.
55Osteoarthritis and Cartilage Vol. 16, No. 1chondrocytes. Its expression then decreased progressively
during monolayer culture. During dedifferentiation, the ex-
pression of PCSK1N was down-regulated in cells from
two out of three donors, whereas expression of HTRA1
seemed to be donor-dependent. In sum, SERPINA1 and
A3 mRNA levels correlated best to COL2A1 expression
during dedifferentiation in culture. As SERPINA1 achieved
higher expression levels and as, it was consistently down-
regulated during dedifferentiation and consistently up-
regulated during in vitro chondrogenesis, it appeared as
the most interesting candidate for evaluation on the protein
level.CORRELATION OF SERPINA1 SECRETION WITH
CHONDROGENIC DIFFERENTIATION OF BMSCs AND
DEDIFFERENTIATION OF CHONDROCYTES IN
MONOLAYER CULTURECell culture medium conditioned for 4 days with one
spheroid from three distinct donors was assessed for the
secretion of SERPINA1 protein at weeks 5, 7, 9 and 11 after
start of chondrogenic induction [Fig. 5(A)]. The SERPINA1
concentration assessed by ELISA rose from a mean of
4.5 ng/ml at day 0 (plain medium) to a mean of 50.6 ng/
ml/4days after 11 weeks of chondrogenic induction. Since
the DNA content of the spheroids decreased over that
time to about 70% of initial values, this up-regulation is at-
tributed to cell differentiation rather than cell expansion. In
parallel, the SERPINA1 secretion by chondrocytes dropped
during expansion in monolayer culture in all ﬁve donors an-
alysed [Fig. 5(B)]. Levels in cell culture media conditioned
with 5 105 freshly isolated chondrocytes for 4 days de-
creased from a mean of 288 ng/ml SERPINA1 to 27e42%
of the initial levels in all donors (P< 0.05) when cells from
pd6 were assessed. Western blot analysis [Fig. 5(C)] shows
that the secreted SERPINA1 protein corresponds to
a blurred single band close to the 54 kDa band of humanplasma SERPINA1, possibly indicating a different glycosyl-
ation status of the protein secreted by chondrocytes
in vitro22.Discussion
Although the differentiation potential of MSCs towards the
chondrogenic lineage has long been established in various
approaches1,2, the hallmarks of MSCs’ differentiation into
articular chondrocytes remain only partially deﬁned. For
molecular analysis of cartilage regenerates the knowledge
of cartilage-relevant differentiation and dedifferentiation
markers is demanded. In order to identify such marker mol-
ecules, a 30,000-gene fragment array was used, allowing
an almost genome-wide screening for differential gene ex-
pression in cartilage and MSCs. On this array 31,488
cloned gene fragments were represented and data analysis
selected 105 differentially expressed genes with a more
than three-fold difference in expression between cartilage
and MSC. After sequence veriﬁcation 87 differentially
expressed genes have ﬁnally been identiﬁed. Differential
expression was validated by real-time PCR for 18 genes,
representing a validation rate of 69%, which is in line with
the literature23. Since OA cartilage was used for cDNA anal-
ysis, the expression of identiﬁed candidate genes was also
evaluated by RT-PCR in healthy cartilage.
Among the genes identiﬁed, a large number of known
cartilage-relevant genes such as collagen type II, aggre-
can, decorin, connective tissue growth factor (CTGF), or in-
tegrin alpha 10 was found within the cartilage tissue but not
within the MSC group, which is an evidence for the high
quality of our data analysis. We identiﬁed SERPINA1 as
an attractive new differentiation marker since its gene ex-
pression and protein secretion correlated consistently with
chondrogenic differentiation of MSCs and dedifferentiation
of expanded chondrocytes in culture. To the best of our
Fig. 3. Quantitative gene expression analysis during the chondrogenic differentiation of BMSCs. Expression levels of COL2A1, MMP3, SER-
PINA1, A3 (n¼ 5), HTRA1 and C5orf4 (n¼ 2) were assessed by real-time RT-PCR at days 0, 14, 28 and 42 after chondrogenic induction of
BMSC spheroid cultures with TGF b3 (, and 6 represent two donors). For each cDNA sample, the concentration of the reference house-
keeping gene b-actin (ACTB) was used to normalise all genes tested. For COL2A1, MMP3, SERPINA1 and A3, mean values were calculated.
*Signiﬁcant differences to time point 0 (P< 0.05).
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amount of a secreted marker protein in conditioned culture
supernatant to the differentiation stage of cultured MSCs
and chondrocytes.
The serpins are a superfamily of proteins comprising at
least 35 human members which are involved in various bi-
ological processes21. They are characterised by the unique
suicide substrate-like inhibitory mechanism they employ.
Most serpins inhibit serine proteinases of the chymotrypsin
family, but some cross-class inhibitors have been identiﬁed
and several members no longer function as proteinase in-
hibitors. Serpins can be inactivated by various MMPs24.SERPINA1 and A3 in particular have been shown to be in-
activated by MMP325. For this reason, it is tempting to spec-
ulate that the two dedifferentiation markers SERPINA1 and
MMP3 may be counter actors in the homeostasis of carti-
lage matrix.
SERPINA1 has been shown to be expressed in cultured
human chondrocytes and up-regulated after IL-6 treat-
ment26. It is also expressed in human cartilage, where de-
creased constitutive levels in OA cartilage as compared to
normal cartilage have been noted27 [Fig. 4(A)]. SERPINA1
can inhibit the action of plasmin, which may be a key
activator of the pro-enzymes proMMP1 and proMMP3 in
Fig. 4. (A) Expression of SERPINA1 and A3 in normal (N) cartilage (n¼ 5) and OA cartilage samples (n¼ 8). Expression levels were assessed
by real-time RT-PCR. For each cDNA sample, the concentration of the reference housekeeping gene b-actin (ACTB) was used to normalise
expression. (B) Expression of COL2A1, SERPINA1, A3, F1, MMP3, PCSK1N and HRTA1in cartilage and in dedifferentiating chondrocytes.
RT-PCR was conducted with cartilage (C) and corresponding chondrocytes after digestion of cartilage (pd0), after pd2 and after pd6 from
three donors. The concentrations of templates used in the reactions were adjusted according to GAPDH signals in order to achieve compa-
rable signals. PCR products were visualised by agarose gel electrophoresis.
57Osteoarthritis and Cartilage Vol. 16, No. 1cartilage and blocks the interleukin1 (IL-1) and plasmino-
gen dependent glycosaminoglycan (GAG) release of bovine
cartilage explants28 as well as the IL-1/oncostatin-depen-
dant collagen degradation in bovine nasal cartilage explant
cultures29. These effects of SERPINA1 have beenattributed to a blockage of the activation of procollage-
nases and suggest a protective role for serine proteinases
in the activation cascades of collagenases that initiate the
breakdown of cartilage matrix. Most remarkably we now
demonstrate that this inhibitor can serve as a marker of
Fig. 5. Secretion of the SERPINA1 protein during the chondrogenic
differentiation of BMSCs and the dedifferentiation of chondrocytes.
Protein concentrations were assessed by ELISA in cell culture me-
dia conditioned for 4 days. (A) Supernatants from spheroids with
5 105 cells were measured after 5, 7, 9 and 11 weeks of chondro-
genic induction for three donors. (B) Supernatants from 5 105
chondrocytes after digestion of cartilage (pd0), after pd2 and after
pd6 were measured for ﬁve donors. SERPINA1 concentration after
pd6 was signiﬁcantly lower than from freshly isolated cells
(P< 0.05). (C) Serum-free cell culture medium of freshly isolated
chondrocytes conditioned for 3 days was used for immunoblotting.
Western blot analysis of concentrated medium revealed a single
band close to 54 kDa (lane 2). In lane one, 1 mg human plasma
SERPINA1 was blotted as positive control.
58 S. Boeuf et al.: Gene expression of cartilage and MSCschondrogenesis in MSCs and of dedifferentiation in cul-
tured chondrocytes.
According to our data other proteases and protease inhib-
itors expressed in cartilage could further be used as differ-
entiation markers. Among them is another serpin,
SERPINA3, whose expression proﬁle was similar to that
of SERPINA1, but showed much lower mRNA expression
levels. It was identiﬁed to be expressed in adult, healthy
or OA cartilage8 as well as in foetal cartilage7. For a better
evaluation of SERPINA3 as a differentiation marker a quan-
titative protein assay is needed to assess its protein expres-
sion and secretion by chondrocytes.
A further potentially interesting inhibitor is the proprotein
convertase subtilisin/kexin type 1 inhibitor (PCSK1N, also
termed proSAAS), which was only weakly down-regulated
during dedifferentiation of chondrocytes. The protein is
cleaved in several smaller peptides which may function as
endogenous inhibitors of prohormone convertase 1 (PC1).
A role in cellecell signalling has also been proposed30,31.For the HtrA serine peptidase 1 (HTRA1) no regulation
was found during dedifferentiation and published data indi-
cate that it may rather be associated to hypertrophic differ-
entiation32. Several compounds of cartilage ECM have
been identiﬁed as substrates for HTRA1: aggrecan, de-
corin, ﬁbromodullin, collagen type II and ﬁbronectin33,32. In-
terestingly HTRA1 has been shown to form a stable
complex with SERPINA1 and to be inhibited by this prote-
ase inhibitor34 indicating that an interacting network of pro-
teases (HTRA1, MMP3) and inhibitors may be regulated
during differentiation.
Besides the genes analysed in more detail, other poten-
tially interesting markers may arise from the 87 genes iden-
tiﬁed in this study, like TSC22, potentially playing
a stimulatory role in chondrogenesis35; calsyntenin, poten-
tially implicated in cell adhesion36 or the antiangiogenic fac-
tor SERPINF1, identiﬁed in MSCs.
Altogether, comparative cDNA-array analysis between
MSCs and cartilage revealed new transcripts, genes with
established or putative function in chondrogenesis as well
as new candidate molecules relevant for chondrocyte differ-
entiation. The expression of distinct proteases and protease
inhibitors correlated to the differentiation of MSCs and the
dedifferentiation of chondrocytes during monolayer expan-
sion and expression of SERPINA1, both on the mRNA
and the protein level, could be used as an indicator for
the differentiation stage of the cells. Most attractively SER-
PINA1 is released into the medium of cultured cells which
will allow correlation of the concentration of this factor to func-
tional parameters like ectopic cartilage formation capacity of
chondrocytes in future studies. This could yield attractive
quality control parameters for chondrocytes used in cell ther-
apy and tissue engineering approaches. Most interestingly,
protease inhibitors like SERPINA1 may play a protective
role against matrix degradation not only during cartilage de-
velopment and regeneration but also under inﬂammatory
and degenerative conditions found in joint diseases.Acknowledgments
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